Pharmaceutical Industry Analysis
🇺🇸 FDAExpert commentary and market intelligence for pharma strategy teams
Showing 1–12 of 21 articles
Biosimilars Drive Significant Reductions in Specialty Drug Spending
EU Publishes Roadmap to Reduce Animal Testing: Implications for Pharma
Medicare's GLP-1 Stance and UnitedHealthcare Lawsuit: Key Implications for Pharma
ASCO 2026: Grief Takes Center Stage Amidst Cancer Data
Research Progress and Development Strategies of Antibody-Oligonucleotide Conjugates
Sen. Dick Durbin: Trump is Letting Big Tobacco Target Children
Lantheus Considers $7B Acquisition of Curium: Implications for Pharma
Understanding the Financial Implications of STAT+: $775 Billion, $1.2 Billion, and $38K
Astellas Cuts Costs Amid FDA Review of Moderna Vaccine
#ASCO26: Kelun's Phase 3 Lung Cancer Success with Merck
BioMarin's Study Success: Implications for Pharma Expansion
Elevance Executive Testifies in Medicare Advantage Fraud Case